Sevres, undefined

Pierre Simon

This inventor holds 1 USPTO granted patent. Top assignee: Union Chimique Continentale-u.c.c. Active years: 1976.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pierre Simon. Retrieved from https://idiyas.com/inventor/pierre-simon-yuqakp4f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pierre Simon: Innovator in Pharmaceutical Compositions

Introduction

Pierre Simon is a notable inventor based in Sèvres, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of psychostimulant compositions. His work has the potential to impact various therapeutic applications.

Latest Patents

Pierre Simon holds a patent for pharmaceutical compositions containing 6-Methyl-3,4-diphenyl-3,4,5,6-tetrahydro-2-pyrone or its derivatives. These compounds are recognized as psychostimulants that can be administered through various routes, including orally, parenterally, and rectally. An effective oral dose for an adult is specified to be between 100-1000 mg/day. This patent highlights his innovative approach to enhancing the efficacy of psychostimulant medications.

Career Highlights

Pierre Simon is associated with Union Chimique Continentale, a company that focuses on chemical innovations. His role in this organization has allowed him to further his research and development efforts in the pharmaceutical sector. His dedication to advancing medical science is evident through his patent and ongoing work.

Collaborations

(Section skipped due to space constraints.)

Conclusion

Pierre Simon's contributions to pharmaceutical compositions demonstrate his commitment to innovation in the field. His patent reflects a significant advancement in psychostimulant therapies, showcasing his expertise and dedication to improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…